pfizer

ASX shakes off sentiment, IT recovery, Charter Hall, Reliance deliver records The ASX200 (ASX: XJO) shook off a rare negative week to open 0.4% higher on Monday. The IT and property sectors, up 1.7 and 0.9% respectively were the key contributors as reporting season continued. Energy remains under pressure with Ampol (ASX: ALD) down 4.8% on a weaker earnings report and…

Bank rally not enough, Westpac hike dividend, job ads continue to surprise The ASX200 (ASX:XJO) rose just three points to begin the week, with a powerful day from the financials sector (+1.4%) which represents some 30% of the index not enough to overcome broader weakness. Energy and materials continue to detract amid signs that inflation is being…

A major milestone for Pfizer On 9 November 2020, Pfizer announced that its vaccine candidate, developed in collaboration with BioNTech, was more than 90 per cent effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis. After discussion with the US Food and Drug Administration (FDA), Pfizer…

Trillion-dollar French asset manager Amundi released their November Cross Asset Strategy report last week, with gold bullion and active management among their highest conviction calls. The group is renowned for their institutional investment capacity but particular their ESG or Sustainability credentials. With Pfizer’s (NYSE: PFE) vaccine news coming shortly after the release, CIO Pascal Blanque…